Search

everythinglearnresearchcommunity

for

Search:↓

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

The document concludes that modern photo stories help represent and challenge how breast cancer affects women's identities and societal norms.

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Septin4 helps kill colon cancer cells by working with the protein BAX.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Surgeons' testosterone levels significantly increase during major head and neck cancer surgeries.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Women with pancreatic cancer are more likely to have certain side effects from chemotherapy than men.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

The number of advanced breast cancer cases in women under 40 has increased, but the overall numbers are still low.

Mutations in iRhom2 affect hair and skin in mice and are linked to esophageal cancer, with ADAM17 playing a crucial role.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Children with cancer had slightly more unusual facial shapes than healthy kids, but not enough to easily tell them apart.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

The paper concludes that breast cancer treatment involves complex interactions between medical symptoms, patient experiences, and commercial influences, requiring a holistic approach.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Haircuts and medical growth factors do not cause cancer.

Metastatic cervical cancer can cause rare, severe Cushing's syndrome with high risk of death.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Physical activity, height, and smoking affect prostate cancer risk.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.